Neumora Therapeutics (NMRA) Institutional Ownership $0.75 +0.02 (+3.41%) Closing price 04:00 PM EasternExtended Trading$0.75 0.00 (-0.21%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Neumora Therapeutics (NASDAQ:NMRA)CurrentInstitutional OwnershipPercentage47.65%Number ofInstitutional Buyers(last 12 months)68TotalInstitutional Inflows(last 12 months)$113.93MNumber ofInstitutional Sellers(last 12 months)23TotalInstitutional Outflows(last 12 months)$51.04M Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NMRA Institutional Buying and Selling by Quarter Neumora Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.607,784$608K0.0%-5.2%0.376% 5/16/2025 AQR Capital Management LLC462,603$463K0.0%N/A0.286% 5/16/2025 ADAR1 Capital Management LLC26,108$26K0.0%-61.9%0.016% 5/15/2025 Graham Capital Management L.P.1,162,499$1.16M0.0%+1,643.7%0.719% 5/15/2025 Siren L.L.C.4,358,283$4.36M0.3%-0.9%2.694% 5/14/2025 Jump Financial LLC24,947$25K0.0%N/A0.015% 5/14/2025 T. Rowe Price Investment Management Inc.2,103,029$2.10M0.0%-58.0%1.300% 5/12/2025 Nuveen LLC220,970$221K0.0%N/A0.137% 5/12/2025 Aigen Investment Management LP36,360$36K0.0%N/A0.022% 5/12/2025 Virtu Financial LLC39,676$40K0.0%N/A0.025% Get the Latest News and Ratings for NMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2025 Invesco Ltd.123,655$124K0.0%+151.1%0.076% 5/9/2025 Charles Schwab Investment Management Inc.593,498$593K0.0%-15.7%0.367% 5/8/2025 XTX Topco Ltd233,597$234K0.0%+969.7%0.144% 5/8/2025 Federated Hermes Inc.284,576$285K0.0%N/A0.176% 5/1/2025 CWM LLC25,213$25K0.0%+7,124.4%0.016% 4/30/2025 Cerity Partners LLC302,505$303K0.0%+24.0%0.187% 4/30/2025 Alps Advisors Inc.114,371$114K0.0%-12.5%0.071% 4/25/2025 Lunate Capital Ltd2,124,143$2.12M1.2%N/A1.313% 3/18/2025 California State Teachers Retirement System54,457$577K0.0%+793.5%0.034% 2/26/2025 Windmill Hill Asset Management Ltd104,373$1.11M0.4%+299.6%0.065% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC72,622$770K0.0%N/A0.045% 2/17/2025 Wexford Capital LP252,122$2.67M0.4%+15.7%0.156% 2/17/2025 Toronto Dominion Bank34,300$364K0.0%N/A0.021% 2/17/2025 Stempoint Capital LP428,137$4.54M1.1%N/A0.265% 2/17/2025 Softbank Group CORP.6,541,190$69.34M0.3%-13.3%4.049% 2/17/2025 Rafferty Asset Management LLC17,431$185K0.0%N/A0.011% 2/17/2025 Numerai GP LLC51,696$548K0.2%+46.7%0.032% 2/17/2025 Orbimed Advisors LLC804,996$8.53M0.2%-46.3%0.498% 2/17/2025 Janus Henderson Group PLC26,500$281K0.0%N/A0.016% 2/17/2025 Graham Capital Management L.P.66,669$707K0.0%N/A0.041% 2/17/2025 Deutsche Bank AG73,103$775K0.0%+50.4%0.045% 2/17/2025 Cutter Capital Management LP150,000$1.59M0.7%N/A0.093% 2/17/2025 Brevan Howard Capital Management LP80,559$854K0.0%N/A0.050% 2/17/2025 BNP Paribas Financial Markets20,885$221K0.0%N/A0.013% 2/17/2025 Ameriprise Financial Inc.118,674$1.26M0.0%N/A0.073% 2/14/2025 PDT Partners LLC25,023$265K0.0%-20.1%0.015% 2/14/2025 Schonfeld Strategic Advisors LLC521,013$5.52M0.0%+273.9%0.322% 2/14/2025 Northern Trust Corp734,847$7.79M0.0%+7.7%0.455% 2/14/2025 The Manufacturers Life Insurance Company45,060$478K0.0%-59.0%0.028% 2/14/2025 T. Rowe Price Investment Management Inc.5,002,799$53.03M0.0%-4.3%3.097% How Trade Wars Are Creating Fresh Opportunities for Investors (Ad)Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”Position yourself ahead of the next move—get the full report here.2/14/2025 Price T Rowe Associates Inc. MD32,548$346K0.0%-94.8%0.020% 2/14/2025 Soros Capital Management LLC279,333$2.96M0.5%-45.1%0.173% 2/14/2025 Rock Springs Capital Management LP955,106$10.12M0.4%+15.3%0.591% 2/14/2025 Capital International Investors3,700,359$39.22M0.0%+692.1%2.290% 2/13/2025 PEAK6 LLC11,057$117K0.0%N/A0.007% 2/13/2025 XTX Topco Ltd21,838$231K0.0%N/A0.014% 2/13/2025 Barclays PLC166,822$1.77M0.0%+29.1%0.103% 2/13/2025 Legal & General Group Plc59,842$634K0.0%+526.4%0.037% 2/13/2025 Invesco Ltd.49,249$522K0.0%+254.1%0.030% 2/13/2025 ADAR1 Capital Management LLC68,608$727K0.1%N/A0.042% 2/13/2025 Wells Fargo & Company MN70,653$749K0.0%+23.0%0.044% 2/12/2025 Geode Capital Management LLC1,970,280$20.89M0.0%-0.5%1.220% 2/12/2025 Franklin Resources Inc.31,357$332K0.0%-58.6%0.019% 2/12/2025 Alliancebernstein L.P.199,947$2.12M0.0%-10.3%0.124% 2/12/2025 Norges Bank110,000$1.17M0.0%N/A0.068% 2/11/2025 EntryPoint Capital LLC12,762$135K0.1%N/A0.008% 2/11/2025 Vanguard Group Inc.4,572,308$48.47M0.0%+4.5%2.830% 2/11/2025 KLP Kapitalforvaltning AS13,500$143K0.0%N/A0.008% 2/11/2025 Quantbot Technologies LP8,646$92K0.0%N/A0.005% 2/11/2025 Teacher Retirement System of Texas16,669$177K0.0%N/A0.010% 2/10/2025 Swiss National Bank110,200$1.17M0.0%N/A0.068% 2/7/2025 PNC Financial Services Group Inc.6,000$64K0.0%N/A0.004% 2/7/2025 AMG National Trust Bank43,379$480K0.0%N/A0.027% 2/7/2025 Candriam S.C.A.571,027$6.05M0.0%-15.6%0.353% 2/6/2025 Arizona State Retirement System16,222$172K0.0%N/A0.010% 2/6/2025 Charles Schwab Investment Management Inc.704,154$7.46M0.0%+0.8%0.436% 2/3/2025 Callan Capital LLC636,194$6.74M0.5%-3.8%0.394% 2/3/2025 Ieq Capital LLC36,853$391K0.0%-50.8%0.023% 1/31/2025 Addis & Hill Inc163,386$1.73M1.3%-45.5%0.101% 1/28/2025 Windmill Hill Asset Management Ltd104,373$1.11M1.1%+299.6%0.065% 1/27/2025 Mirae Asset Global Investments Co. Ltd.5,384$61K0.0%N/A0.003% 1/24/2025 SkyOak Wealth LLC20,000$212K0.0%+33.3%0.012% 1/24/2025 China Universal Asset Management Co. Ltd.34,257$363K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC14,119$150K0.0%-34.6%0.009% 12/26/2024 JPMorgan Chase & Co.64,421$851K0.0%+2.6%0.040% 11/27/2024 Franklin Resources Inc.75,702$1M0.0%-13.9%0.047% 11/19/2024 Barclays PLC129,210$1.71M0.0%+352.9%0.080% 11/16/2024 Geode Capital Management LLC1,979,847$26.16M0.0%+54.0%1.225% 11/15/2024 Barclays PLC129,210$1.71M0.0%+352.9%0.080% 11/15/2024 Wexford Capital LP217,879$2.88M0.7%+90.1%0.135% 11/15/2024 State Street Corp1,790,707$23.66M0.0%+65.3%1.108% 11/15/2024 Quarry LP5,000$66K0.0%-50.0%0.003% 11/15/2024 Point72 Asset Management L.P.83,077$1.10M0.0%N/A0.051% 11/13/2024 FMR LLC7,749,156$102.37M0.0%-10.1%4.842% 11/13/2024 The Manufacturers Life Insurance Company109,802$1.45M0.0%-1.8%0.069% 11/12/2024 Cerity Partners LLC242,900$3.21M0.0%N/A0.152% 11/12/2024 Charles Schwab Investment Management Inc.698,255$9.22M0.0%+139.7%0.436% 11/9/2024Intech Investment Management LLC13,275$175K0.0%N/A0.008% 10/30/2024 Auour Investments LLC250,000$3.30M1.2%N/A0.156% 10/23/2024 Ballentine Partners LLC13,441$178K0.0%N/A0.008% Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now10/9/2024 Clarius Group LLC16,992$224K0.0%N/A0.011% 10/5/2024 Handelsbanken Fonder AB26,600$351K0.0%+35.0%0.017% 10/3/2024 SG Americas Securities LLC21,581$285K0.0%-62.5%0.014% 8/27/2024 Logos Global Management LP300,000$2.95M0.2%-21.5%0.188% 8/16/2024 Quarry LP10,000$98K0.0%N/A0.006% 8/15/2024 The Manufacturers Life Insurance Company111,828$1.10M0.0%+79.5%0.070% 8/14/2024 Marshall Wace LLP134,545$1.32M0.0%N/A0.084% 8/14/2024 Logos Global Management LP300,000$2.95M0.2%-21.5%0.188% 8/13/2024 Callan Capital LLC661,194$6.50M0.5%+222.6%0.414% 8/12/2024 SkyOak Wealth LLC15,000$147K0.0%N/A0.009% (Data available from 1/1/2016 forward) NMRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NMRA shares? During the previous two years, 97 institutional investors and hedge funds held shares of Neumora Therapeutics. The most heavily invested institutionals were FMR LLC ($102.37M), Softbank Group CORP. ($69.34M), Vanguard Group Inc. ($48.47M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($46.69M), Artal Group S.A. ($40.21M), Capital International Investors ($39.22M), and Avidity Partners Management LP ($33.94M).Learn more on NMRA's institutional investors. What percentage of Neumora Therapeutics stock is owned by institutional investors? 47.65% of Neumora Therapeutics stock is owned by institutional investors. Learn more on NMRA's institutional investor holdings. Which institutional investors have been buying Neumora Therapeutics stock? Of the 84 institutional investors that purchased Neumora Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.62M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($3.31M), Capital International Investors ($3.23M), Lunate Capital Ltd ($2.12M), Avidity Partners Management LP ($1.99M), Graham Capital Management L.P. ($1.16M), and Johnson & Johnson ($912.13K). How much institutional buying is happening at Neumora Therapeutics? Institutional investors have bought a total of 28,880,823 shares in the last 24 months. This purchase volume represents approximately $318.37M in transactions. Which Neumora Therapeutics major shareholders have been selling company stock? Of the 24 institutional investors that sold Neumora Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($3.13M), Softbank Group CORP. ($1.01M), FMR LLC ($873.31K), Orbimed Advisors LLC ($695.00K), Price T Rowe Associates Inc. MD ($592.93K), Soros Capital Management LLC ($229.58K), and Logos Global Management LP ($164.69K). How much institutional selling is happening at Neumora Therapeutics? Institutional investors have sold a total of 7,489,024 shares in the last 24 months. This volume of shares sold represents approximately $51.68M in transactions. Related Companies Maze Therapeutics Institutional Ownership SIGA Technologies Institutional Ownership Zevra Therapeutics Institutional Ownership Sage Therapeutics Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership Prothena Institutional Ownership PureTech Health Institutional Ownership ABIVAX Société Anonyme Institutional Ownership Tourmaline Bio Institutional Ownership Precigen Institutional Ownership This page (NASDAQ:NMRA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NMRA Stock Free NMRA Stock Alerts